Cargando…
TWIST1 Gene Expression as a Biomarker for Predicting Primary Doxorubicin Resistance in Breast Cancer
Doxorubicin is one of the most commonly used chemotherapeutic agents for adjuvant chemotherapy of breast cancer. In the studies focused on finding biomarkers to predict the response of the patients and tumors to the drugs used, the Twist transcription factor has been suggested as a candidate biomark...
Autores principales: | Demir, S, Müslümanoğlu, MH, Müslümanoğlu, M, Başaran, S, Çalay, ZZ, Aydıner, A, Vogt, U, Çakır, T, Kadıoğlu, H, Artan, S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sciendo
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956638/ https://www.ncbi.nlm.nih.gov/pubmed/31942413 http://dx.doi.org/10.2478/bjmg-2019-0025 |
Ejemplares similares
-
Comparison of the histopathology and prognosis of bilateral versus unilateral multifocal multicentric breast cancers
por: Kadioğlu, Hüseyin, et al.
Publicado: (2014) -
Ischemia Modified Albumin Can Predict Necrosis at Incarcerated Hernias
por: Kadioğlu, Hüseyin, et al.
Publicado: (2013) -
Metaplastic Breast Carcinoma Versus Triple-Negative Breast Cancer: Survival and Response to Treatment
por: Aydiner, Adnan, et al.
Publicado: (2015) -
C1-2 posterior arthrodesis technique with a left segmental and right transarticular fixation. A hybrid novel (Kotil) technique
por: Kotil, Kadir, et al.
Publicado: (2014) -
TIM3 expression on TILs is associated with poor response to neoadjuvant chemotherapy in patients with locally advanced triple-negative breast cancer
por: Cabioglu, Neslihan, et al.
Publicado: (2021)